| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Halozyme Therapeutics, Inc. (HALO) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 16 sells. HALO is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 777.8K | $53.66M | - | |
| Dir | 77.8K | $5.37M | - | |
| Dir | 43.7K | $3.01M | -1,625 | |
| Dir | 36.6K | $2.52M | - | |
| Dir | 23.7K | $1.64M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 27, 2023 | Torley Helen61 | President And CEO | Sale+OE | 30,000 | $43.09 | $1,292,750.00 | -1.6% | -23.4% | +29.2% | |
| Jul 18, 2023 | Labarre Michael J.52 | SVP, Chief Technical Officer | Sale+OE | 10,000 | $40.43 | $404,300.00 | -6.6% | -11.2% | +31.3% | |
| Jun 21, 2023 | Labarre Michael J.52 | SVP, Chief Technical Officer | Sale+OE | 10,000 | $36.00 | $360,000.00 | -6.6% | +10.1% | +40.8% | |
| Apr 18, 2023 | Labarre Michael J.52 | SVP, Chief Technical Officer | Sale+OE | 10,000 | $36.00 | $360,000.00 | -6.6% | +12.8% | +6.5% | |
| Mar 9, 2023 | Torley Helen61 | President And CEO | Sale+OE | 30,000 | $43.82 | $1,314,550.00 | -1.6% | -18.8% | -2.4% | |
| Mar 1, 2023 | Henderson Jeffrey William65 | Director | Sell | 20,000 | $48.11 | $962,200.00 | -18.5% | -31.0% | -16.4% | |
| Feb 27, 2023 | Labarre Michael J.52 | SVP, Chief Technical Officer | Sell | 10,000 | $49.55 | $495,482.98 | -3.4% | -32.3% | -17.9% | |
| Feb 16, 2023 | Labarre Michael J.52 | SVP, Chief Technical Officer | Sale+OE | 2,878 | $49.26 | $141,770.28 | -1.9% | -32.1% | -26.7% | |
| Feb 16, 2023 | Torley Helen61 | President And CEO | Sale+OE | 11,061 | $49.26 | $544,864.86 | -1.7% | -32.1% | -26.7% | |
| Feb 16, 2023 | Labrosse Nicole60 | SVP, Chief Financial Officer | Sale+OE | 2,525 | $49.26 | $124,381.50 | -21.8% | -32.1% | -26.7% |